Post-viral lung diseases: the microbiota as a key player

Area of Science:

• Pulmonology and Microbiology
• Immunology
• Infectious Diseases

Background:

• Viral respiratory infections can lead to chronic lung injury via unclear immunopathological pathways.
• The respiratory tract microbiota is altered during viral infections, potentially worsening inflammation and lung damage.
• Post-viral lung injury involves complex interactions between viral infections, immune responses, and airway microbiota composition.

Purpose of the Study:

• To review the clinical features of post-viral lung injury.
• To elucidate the immunopathological mechanisms and host-bacteria interactions in viral-induced lung diseases.
• To highlight the role of the airway microbiota in viral-induced pulmonary sequelae and suggest future research directions.

Main Methods:

• Literature review focusing on clinical characteristics, immunopathology, and host-bacteria interactions.
• Analysis of studies involving influenza virus, respiratory syncytial virus, and coronaviruses.
• Synthesis of evidence on the impact of airway microbiota in post-viral lung disease development.

Main Results:

• Post-viral lung injury involves intricate interplay between viral pathogens, host immunity, and microbial communities.
• Alterations in respiratory microbiota are implicated in the progression of lung damage and inflammation following viral infections.
• Specific viruses like influenza, RSV, and coronaviruses exemplify these complex pathogen-host-microbiota dynamics.

Conclusions:

• Understanding the interplay between viral infections and the airway microbiota is crucial for managing post-viral lung injury.
• Further research into respiratory microbiota's role is essential for developing targeted therapies for viral-induced lung diseases.
• The airway microbiota represents a key factor in the pathogenesis and potential treatment of chronic lung conditions post-viral infection.